8 Stocks Rising on Unusual Volume
XenoPort
XenoPort (XNPT) is a biopharmaceutical company focused on developing and commercializing a portfolio of internally for the treatment of neurological disorders. This stock is trading up 9.6% at $12.23 in recent trading.
Today's Volume: 498,000
Average Volume: 446,355 Volume % Change: 106% >>4 Biotech Stocks Under $10 Moving Higher Shares of XNPT are skyrocketing today after Leerink said the preliminary results for its Phase I trial testing for different oral formulations of XP23829 is encouraging. The firm kept its outperform rating on the stock and raised its price target to $15 from $13. From a technical perspective, XNPT is bouncing hard here right off some near-term support at $10.90 with above-average volume. This move has also pushed XNPT into breakout territory, since the stock has busted above some near-term overhead resistance at $11.86. At last check, XNPT has hit an intraday high of $12.52 and volume has just started to surpass its three-month average volume of 446,355 shares. Traders should now look for long-biased trades in XNPT as long as it's trending above $11.20 to $11.86 with strong upside volume flows. I would consider any upside volume day that registers near or above 446,355 shares as bullish. If XNPT can maintain that trend, especially its trend above $11.86, then this stock has a great chance of tagging $15 in the near future.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
